- Home
- BFRI vs ZBAI Comparison
BFRI vs ZBAI Comparison
Compare BFRI & ZBAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BFRI | ZBAI |
|---|---|---|
| Founded | 1997 | 2015 |
| Country | United States | United States |
| Employees | 93 | 6 |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.6M | 68.1M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BFRI | ZBAI |
|---|---|---|
| Price | $0.85 | $6.63 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.75 | N/A |
| AVG Volume (30 Days) | ★ 480.9K | 2.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $11.37 | N/A |
| Revenue Next Year | $10.96 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.54 | $0.30 |
| 52 Week High | $1.18 | $11.94 |
Technical Indicators
Market Signals| Indicator | BFRI | ZBAI |
|---|---|---|
| Relative Strength Index (RSI) | 46.11 | 50.34 |
| Support Level | $0.81 | $6.59 |
| Resistance Level | $0.91 | $7.44 |
| Average True Range (ATR) | 0.07 | 0.51 |
| MACD | -0.00 | 0.04 |
| Stochastic Oscillator | 46.44 | 54.49 |
Price Performance
Historical ComparisonAbout BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.
About ZBAI ATIF Holdings Limited Ordinary Shares
ATIF Holdings Ltd is a consulting company. It provides financial consulting services to small and medium-sized enterprises. It operates in one operating segment, which is the consulting service business. The company prominently generated revenues from consulting services to its clients. Geographically, the maximum revenue is derived from Hong Kong.